SOPH logo

SOPH SOPHiA GENETICS S.A.

NASDAQ Global Select · Medical - Healthcare Information Services · Healthcare

$6.23
-0.45 (-6.74%)

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hos…

Market Cap: $530.35Mwww.sophiagenetics.com

Price

No data yet.

Social Signal Score

59
5d
—
30d
59
5 mentions
—
60d
59
5 mentions
—
90d
58
6 mentions
—
news: 6

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 1Sell 0Strong Sell 0
Avg price target$11.5+84.6%
Low $9Median $11.5High $14
Current Consensus

Revenue

$24.27M+224.38%
$5.92M$12.03M$18.15M$24.27M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-1.12
$-1.20–$-1.07
1 analysts
FY2026
$-0.95
$-1.02–$-0.91
2 analysts
FY2027
$-0.58
$-0.63–$-0.56
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ross Muken
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
415
Beta
0.95
Country
CH
Piotroski score
2 / 9 (Weak)
Altman Z-score
-2.04
www.sophiagenetics.com